↓ Skip to main content

Dove Medical Press

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, September 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#28 of 2,578)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
9 news outlets

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
27 Mendeley
Title
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis
Published in
International Journal of Chronic Obstructive Pulmonary Disease, September 2020
DOI 10.2147/copd.s263025
Pubmed ID
Authors

Henrik Watz, Kathleen Rickard, Tara Rheault, Thomas Bengtsson, Dave Singh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 15%
Other 2 7%
Lecturer 2 7%
Student > Master 2 7%
Student > Bachelor 2 7%
Other 3 11%
Unknown 12 44%
Readers by discipline Count As %
Medicine and Dentistry 6 22%
Unspecified 4 15%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Chemical Engineering 1 4%
Nursing and Health Professions 1 4%
Other 3 11%
Unknown 11 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2020.
All research outputs
#738,453
of 25,387,668 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#28
of 2,578 outputs
Outputs of similar age
#21,608
of 424,805 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#1
of 45 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,578 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.